|
1
|
Afonso ML, Capelas ML, Pimenta NM, Santos T, Mäkitie A, Ganhão-Arranhado S, Trabulo C, Dias DDS, Neves PM, Ravasco P. A Systematic Review of Vitamin D Supplementation in Oncology: Chance of Science or Effectiveness? Nutrients 2025; 17:634. [PMID: 40004963 PMCID: PMC11858158 DOI: 10.3390/nu17040634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2024] [Revised: 01/31/2025] [Accepted: 02/02/2025] [Indexed: 02/27/2025] Open
Abstract
BACKGROUND Vitamin D (VD) supplementation has increased considerably in the last decade, whether for the prevention or treatment of numerous diseases, including bone, cardiovascular, endocrine, neurologic, psychological, respiratory, infectious, or oncological. The primary objective of this scoping review was to examine and synthesize the scientific evidence on the role of VD in all-type cancer patients undergoing adjuvant and neoadjuvant therapy with chemotherapy (CT) or radiotherapy (RT), namely in improving side effects. METHODS This review was conducted by selecting papers from the CINAHL, Scopus and PubMed databases based on the descriptor terms mesh and title/abstract, taking into consideration the defined inclusion and exclusion criteria, following the PRISMA-ScR (PRISMA extension for scoping reviews) statement. RESULTS A total of 758 papers were identified in different databases during this review. However, using the inclusion and exclusion criteria, only five publications made up the final sample of the study. The studies included heterogeneous study methodologies, objectives, cancer diagnosis, as well as methods to assess body composition, which makes it difficult to compare them. Based on the analyzed studies, associations were found between bone density and VD in patients who underwent preoperative chemoradiotherapy (CRT). In patients with non-small-cell lung cancer receiving CT, some of the side effects associated with the treatment were attenuated and reduced. In addition, another of the studies analyzed found that VD deficiency (VDD) has been associated with increased peripheral neuropathy (PN) induced by CT in the treatment of breast cancer. VD supplementation was found to be safe and effective. CONCLUSIONS In this scoping review, VD is highlighted as a crucial factor in preventing the side effects of neoadjuvant RT or CT, as well as treating other treatment-related health conditions, such as osteoporosis, as well as ameliorating the side effects (nausea, vomiting, fatigue) associated with aggressive CT and RT.
Collapse
Affiliation(s)
- Marta Lourenço Afonso
- Universidade Católica Portuguesa, Faculty of Health Sciences and Nursing, 1649-023 Lisbon, Portugal;
- Universidade Católica Portuguesa, Faculty of Health Sciences and Nursing, Centre for Interdisciplinary Research in Health (CIIS), 1649-023 Lisbon, Portugal; (N.M.P.); (T.S.); (A.M.); (S.G.-A.); (C.T.); (D.d.S.D.); (P.M.N.); (P.R.)
| | - Manuel Luís Capelas
- Universidade Católica Portuguesa, Faculty of Health Sciences and Nursing, 1649-023 Lisbon, Portugal;
- Universidade Católica Portuguesa, Faculty of Health Sciences and Nursing, Centre for Interdisciplinary Research in Health (CIIS), 1649-023 Lisbon, Portugal; (N.M.P.); (T.S.); (A.M.); (S.G.-A.); (C.T.); (D.d.S.D.); (P.M.N.); (P.R.)
| | - Nuno M. Pimenta
- Universidade Católica Portuguesa, Faculty of Health Sciences and Nursing, Centre for Interdisciplinary Research in Health (CIIS), 1649-023 Lisbon, Portugal; (N.M.P.); (T.S.); (A.M.); (S.G.-A.); (C.T.); (D.d.S.D.); (P.M.N.); (P.R.)
- Polytechnic Institute of Santarém, Sport Sciences School of Rio Maior, 2040-413 Rio Maior, Portugal
- Interdisciplinary Centre for the Study of Human Performance, Faculdade de Motricidade Humana, Universidade de Lisboa, 1499-002 Lisbon, Portugal
| | - Teresa Santos
- Universidade Católica Portuguesa, Faculty of Health Sciences and Nursing, Centre for Interdisciplinary Research in Health (CIIS), 1649-023 Lisbon, Portugal; (N.M.P.); (T.S.); (A.M.); (S.G.-A.); (C.T.); (D.d.S.D.); (P.M.N.); (P.R.)
- Universidade Europeia, Psychology Department, 1500-210 Lisboa, Portugal
| | - Antti Mäkitie
- Universidade Católica Portuguesa, Faculty of Health Sciences and Nursing, Centre for Interdisciplinary Research in Health (CIIS), 1649-023 Lisbon, Portugal; (N.M.P.); (T.S.); (A.M.); (S.G.-A.); (C.T.); (D.d.S.D.); (P.M.N.); (P.R.)
- Department of Otorhinolaryngology-Head and Neck Surgery, Helsinki University Hospital, University of Helsinki, 00029 HUS Helsinki, Finland
- Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland
- Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institute, Karolinska University Hospital, 171 76 Stockholm, Sweden
| | - Susana Ganhão-Arranhado
- Universidade Católica Portuguesa, Faculty of Health Sciences and Nursing, Centre for Interdisciplinary Research in Health (CIIS), 1649-023 Lisbon, Portugal; (N.M.P.); (T.S.); (A.M.); (S.G.-A.); (C.T.); (D.d.S.D.); (P.M.N.); (P.R.)
- Atlântica, Instituto Universitário, Fábrica da Pólvora de Barcarena, 2730-036 Barcarena, Portugal
- CINTESIS, Centre for Health Technology and Services Research, 4200-450 Porto, Portugal
| | - Carolina Trabulo
- Universidade Católica Portuguesa, Faculty of Health Sciences and Nursing, Centre for Interdisciplinary Research in Health (CIIS), 1649-023 Lisbon, Portugal; (N.M.P.); (T.S.); (A.M.); (S.G.-A.); (C.T.); (D.d.S.D.); (P.M.N.); (P.R.)
- Medical Oncology, Centro Hospitalar Barreiro-Montijo, 2830-003 Barreiro, Portugal
| | - David da Silva Dias
- Universidade Católica Portuguesa, Faculty of Health Sciences and Nursing, Centre for Interdisciplinary Research in Health (CIIS), 1649-023 Lisbon, Portugal; (N.M.P.); (T.S.); (A.M.); (S.G.-A.); (C.T.); (D.d.S.D.); (P.M.N.); (P.R.)
- Medical Oncology Department, Unidade Local de Saúde Cova da Beira, 6200-251 Covilhã, Portugal
- Faculty of Health Sciences, Universidade da Beira Interior, 6200-251 Covilhã, Portugal
| | - Pedro Miguel Neves
- Universidade Católica Portuguesa, Faculty of Health Sciences and Nursing, Centre for Interdisciplinary Research in Health (CIIS), 1649-023 Lisbon, Portugal; (N.M.P.); (T.S.); (A.M.); (S.G.-A.); (C.T.); (D.d.S.D.); (P.M.N.); (P.R.)
| | - Paula Ravasco
- Universidade Católica Portuguesa, Faculty of Health Sciences and Nursing, Centre for Interdisciplinary Research in Health (CIIS), 1649-023 Lisbon, Portugal; (N.M.P.); (T.S.); (A.M.); (S.G.-A.); (C.T.); (D.d.S.D.); (P.M.N.); (P.R.)
- Universidade Católica Portuguesa, Faculty of Medicine, 2635-631 Rio de Mouro, Portugal
- Centre for Interdisciplinary Research in Health Egas Moniz (CiiEM), 2829-511 Almada, Portugal
| |
Collapse
|
|
2
|
Walker SL, Levoy K, Meghani SH. Use of complementary and integrative health in cancer pain management among patients undergoing cancer treatments: a qualitative descriptive study. Support Care Cancer 2022; 30:5147-5156. [PMID: 35237857 DOI: 10.1007/s00520-022-06928-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Accepted: 02/19/2022] [Indexed: 11/30/2022]
Abstract
BACKGROUND Pain is a common symptom in patients undergoing cancer treatment. Despite recommendations for the stronger integration of complementary and integrative health (CIH) in cancer pain management, little is known about the individual experience of using this approach for cancer pain, particularly in certain populations such as African Americans. OBJECTIVE This study aimed to describe the experiences of using CIH for pain in African American and White patients with cancer undergoing cancer treatments. METHODS A secondary analysis of qualitative descriptive data from a subsample of patients with cancer in a parent study of their illness concerns was employed. Atlas.ti 8.0 was used for data management and qualitative analysis. Counts of participant-endorsed themes were tabulated to discern differences in themes by group. RESULTS Of 32 participants (16 African American, 16 White), 22 reported CIH usage for cancer pain management, with equal distribution between groups (11 each). Three themes emerged: Approach to, Reasons for, and Barriers to CIH Use. Psychological approaches were most common (n = 15). Nutritional, physical, and combination approaches were less common and more often employed by White participants. Reasons for CIH use were to reduce opioid consumption or for an opioid adjuvant. Personal limitations and access issues contributed to Barriers to CIH use. CONCLUSIONS Both African American and White patients used CIH for pain management while undergoing cancer treatments. However, some preferential differences in CIH approaches by race surfaced. Further research into these differences may uncover new ways of addressing disparities in cancer pain management with CIH.
Collapse
Affiliation(s)
- Suzanne L Walker
- Abramson Cancer Center, Penn Presbyterian Medical Center, Philadelphia, PA, USA.
| | - Kristin Levoy
- Department of Community and Health Systems, Indiana University School of Nursing, Indianapolis, IN, USA.,Indiana University Center for Aging Research, Regenstrief Institute, Indianapolis, IN, USA.,Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA
| | - Salimah H Meghani
- Department of Biobehavioral Health Sciences, NewCourtland Center for Transitions and Health, Leonard Davis Institute for Health Economics, University of Pennsylvania, Philadelphia, PA, USA
| |
Collapse
|